Research Topic: Phaeohyphomycosis

Phaeohyphomycosis caused by Rhinocladiella similis mimicking Sporotrichosis

mycolabadmin

A 34-year-old factory worker developed multiple nodules on his hand following an injury, initially suspected to be sporotrichosis, a common fungal infection. Through laboratory testing including fungal culture and genetic sequencing, doctors identified the actual cause as a rare fungus called Rhinocladiella similis. The patient was successfully treated with antifungal medication and showed gradual improvement. This is the first case of this fungal infection reported in India.

Read More »

Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with subcutaneous phaeohyphomycosis

mycolabadmin

Researchers identified and described two rare fungal infections caused by Phaeoacremonium species in human patients. One case involved a previously unknown fungal species in humans called Phaeoacremonium indicum, discovered in an Indian transplant patient with a knee infection. Both cases were successfully treated with surgery, with one patient also receiving antifungal medication, demonstrating effective treatment approaches for these unusual infections.

Read More »

Extensive and recurrent infection caused by Medicopsis romeroi in two immunocompromised patients

mycolabadmin

This case report describes two patients with weakened immune systems who developed serious fungal skin infections caused by a rare mold called Medicopsis romeroi. Both patients underwent multiple surgeries and required extended antifungal medication treatment lasting months to years. The study demonstrates that successful treatment requires a combination approach including surgical removal of infected tissue, adjustment of immunosuppressive medications, and prolonged antifungal therapy.

Read More »

Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with subcutaneous phaeohyphomycosis

mycolabadmin

Researchers identified two cases of rare fungal skin infections caused by Phaeoacremonium species. One case involved a new fungal species named Phaeoacremonium indicum discovered in an Indian patient, while the second case from Australia represented the first documented human infection with P. tuscanicum. Both patients were successfully treated through surgical removal of the infected tissue, though one patient was immunocompromised from a kidney transplant. This study highlights how genetic testing helps identify rare fungal species that cause human infections.

Read More »

Phaeohyphomycosis due to Nigrograna chromolaenae in a cardiac transplant patient

mycolabadmin

A 71-year-old heart transplant patient developed a slowly growing bump on his finger caused by a rare fungus called Nigrograna chromolaenae. Doctors initially tried common antifungal medications that didn’t work well, but the patient improved significantly when switched to posaconazole treatment. This is the first documented case of this particular fungus infecting a human, highlighting the importance of accurately identifying fungi to choose the right treatment.

Read More »

Deep cutaneous phaeohyphomycosis caused by Cladophialophora boppii: A case report

mycolabadmin

A 69-year-old woman with breast cancer developed a skin infection caused by a rare fungus called Cladophialophora boppii while taking dexamethasone for cancer treatment. Doctors diagnosed the infection through skin biopsy and fungal testing, then removed the infected area surgically. After three weeks of antifungal medication (itraconazole), the infection cleared completely and did not return during four months of follow-up. This case suggests that surgery combined with short-term antifungal treatment may be sufficient for this type of infection.

Read More »

The Brief Case: Cutaneous ulceration associated with acalabrutinib treatment

mycolabadmin

A 72-year-old patient being treated with acalabrutinib for blood cancer developed a slowly growing skin ulcer on the thigh. Testing identified a fungal infection caused by Alternaria alternata, a mold found in soil and air. The patient was successfully treated with an antifungal medication called posaconazole, with the ulcer healing over one month. This case highlights that doctors should check for fungal infections in chronic skin wounds of patients taking BTK inhibitor medications.

Read More »
Scroll to Top